|
|
|
|
|
20.10.25 - 15:37
|
XFRA: 0RA0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
RAPT THERAP.INC. NEW O.N. 0RA0 US75382E2081
AB/FROM ONWARDS 20.10.2025 15:27 CET...
|
|
|
|
|
20.10.25 - 14:25
|
XFRA: 0RA0: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
RAPT THERAP.INC. NEW O.N. 0RA0 US75382E2081 BAW/UFN...
|
|
|
|
|
19.10.25 - 14:03
|
RAPT Therapeutics to Report Topline Data from Phase 2 Clinical Trial of RPT904 in Chronic Spontaneous Urticaria (CSU) (GlobeNewswire EN)
|
|
|
SOUTH SAN FRANCISCO, Calif., Oct. 19, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that the Company plans to report topline data from the Phase 2 clinical trial of RPT904 (JYB1904) in patients with Chronic Spontaneous Urticaria (CSU) conducted by its partner, Shanghai Jeyou Pharmaceutical Co., Ltd. (Jeyou), formerly called Shanghai Jemincare Pharmaceutical Co., Ltd., in a premarket press release and webcast on Monday, October 20, 2025.RAPT will host a webcast conference call accompanied by a slide presentation on Monday, October 20, 2025 at 8:30 a.m. ET. To join the conference call via phone and participate in the live Q&A session, please pre-register online here to receive a telephone number and unique passcode required to enter the call. The live webcast and audio archive...
|
|
|
|
|
|
|
27.08.25 - 14:03
|
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences (GlobeNewswire EN)
|
|
|
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT management team will participate in the following investor conferences in September:...
|
|
|
|
|
|
|
|
|
|
|
17.06.25 - 16:01
|
XFRA: 0RA0: Wiederaufnahme/Resumption (XETRA)
|
|
|
FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.
THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
RAPT THERAP.INC. NEW O.N. 0RA0 US75382E2081
AB/FROM ONWARDS 17.06.2025 15:54 CET...
|
|
|
17.06.25 - 08:39
|
XFRA: FA20,0RA0,4070: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
FORWARD AIR CORP. O.N. FA20 US34986A1043 BAW/UFN
RAPT THERAP.INC. NEW O.N. 0RA0 US75382E2081 BAW/UFN
SENSEI BIOTHERAPEUT. O.N. 4070 US81728A2078 BAW/UFN...
|
|
|
|
|
16.06.25 - 23:51
|
XFRA: NEW INSTRUMENT AVAILABLE - 17.06.2025 - EQUBF_01 (XETRA)
|
|
|
Das Instrument 0RA0 US75382E2081 RAPT THERAP.INC. NEW O.N. EQUITY hat seinen ersten Handelstag am 17.06.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N
The instrument 0RA0 US75382E2081 RAPT THERAP.INC. NEW O.N. EQUITY has its first trading date on 17.06.2025: CONTINUOUS AUCTION SPECIALIST, PAG PAG_EQU, SettlCurr EUR, CCP N...
|
|
|
16.06.25 - 16:42
|
XFRA: ISIN Change (XETRA)
|
|
|
Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
US31572Q8087 FibroGen Inc. 16.06.2025 US31572Q8814 FibroGen Inc. 17.06.2025 Tausch 25:1
US75382E1091 Rapt Therapeutics Inc. 16.06.2025 US75382E2081 Rapt Therapeutics Inc. 17.06.2025 Tausch 8:1
US81728A1088 Sensei Biotherapeutics Inc. 16.06.2025 US81728A2078 Sensei Biotherapeutics Inc. 17.06.2025 Tausch 20:1
US3498531017 Forward Air Corp. 16.06.2025 US34986A1043 Forward Air Corp. 17.06.2025 Tausch 1:1...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
